2. As of noon trading, Align Technology ( ALGN) is down $1.50 (-5.7%) to $24.64 on heavy volume Thus far, 3.9 million shares of Align Technology exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $23.45-$25.13 after having opened the day at $24.60 as compared to the previous trading day's close of $26.14.

Align Technology, Inc. designs, manufactures, and markets the invisalign system for treating malocclusion or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Align Technology has a market cap of $2.2 billion and is part of the health care sector. The company has a P/E ratio of 31.6, above the S&P 500 P/E ratio of 17.7. Shares are up 10.2% year to date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Align Technology a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Align Technology as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Align Technology Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

Bullish and Bearish Reversals in the Market

As Trump and Trudeau Tout Women's Council, Here's Who Is and Isn't Doing a Good Job at Diversity

Coty Says It Will Add First Woman Board Member by July